Mr. Marcos Agramont reports

ISODIOL INTERNATIONAL INC. LAUNCHES ISOCARE, AN INNOVATIVE PLATFORM FOR THE CANNABIS TREATMENT INDUSTRY

Isodiol International Inc. has launched ISOCare in North American and Latin American markets. ISOCare is an innovative secure platform for the cannabis treatment industry that enables and supports physicians in the longitudinal care of their patients' health. The company had previously announced its licensing agreement with Livecare on Jan. 26, 2018.

ISOCare will allow collaborative care with doctors and mentor-certified cannabis practitioners to achieve health outcomes, including medicinal cannabis therapies. The ISOCare platform connects patients with providers for a medical visit, through a mobile or PC device, eliminating many of the inconveniences faced today in the physician and patient relationship. To access the ISOCare platform, patients must simply complete their initiation form, which doctors then review before connecting with patients by video conference. From there, physicians may prescribe medications or discuss any other concerns.

Additionally, the company believes ISOCare will permit higher patient retention in clinical studies because it will make it easier for enrollees and clinical studies to report back to sponsors.

"We believe ISOCare to be an innovative platform that allows patients' family doctors to involve a certified cannabis physician in continuing longitudinal care while enjoying the benefits of health and wellness products," said Marcos Agramont, chief executive officer of Isodiol. "The company believes ISOCare will also permit higher patient retention in clinical studies, as the process for the patients and clinical studies to report back to sponsors will become much easier. Additionally, this platform allows consumers, particularly in rural areas, to conveniently seek access to our products at their convenience."

Dr. Mark Godley, chief executive officer of Livecare, added, "Livecare is excited to empower ISOCare's platform in its efforts to expand access to physicians with the primary goal of improved longitudinal care."

The company is continuously collaborating with government officials to ensure full compliance with ISOCare, and, as legislation allows, the company will utilize this platform in additional countries. Registration for patients in North American and Latin American markets is being accepted at this time, and patients may visit the ISOCare website to register.

About Isodiol International Inc.

Isodiol is the market leader in pharmaceutical-grade pure, natural CBD (cannabidiol) and the industry leader in the manufacturing and development of CBD consumer products.

Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs and continued international expansion into Latin America, Asia and Europe.

We seek Safe Harbor.